Cleared Traditional

K172450 - TENS device-HeadaTerm

K172450 is the FDA 510(k) clearance for TENS device-HeadaTerm by Wat Medical Technology (Ningbo) Co., Ltd.. It is a Class 2 Neurology device (product code PCC) cleared through the Traditional 510(k) pathway after a 395-day FDA review.

K172450 · Wat Medical Technology (Ningbo) Co., Ltd. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2018
Decision
395d
Days
Class 2
Risk

K172450 is an FDA 510(k) clearance for the TENS device-HeadaTerm, eEspress. Classified as Stimulator, Nerve, Electrical, Transcutaneous, For Migraine (product code PCC), Class II - Special Controls.

Submitted by Wat Medical Technology (Ningbo) Co., Ltd. (Ningbo, CN). The FDA issued a Cleared decision on September 13, 2018 after a review of 395 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5891 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Wat Medical Technology (Ningbo) Co., Ltd. devices

Submission Details

510(k) Number K172450 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 14, 2017
Decision Date September 13, 2018
Days to Decision 395 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
247d slower than avg
Panel avg: 148d · This submission: 395d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code PCC Stimulator, Nerve, Electrical, Transcutaneous, For Migraine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5891
Definition Used To Apply An Electrical Current To A Patient's Cranium Through Electrodes Placed On The Skin.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.